US regulatory status: approved.
pharma · Endometrial Cancer · XBIO
Xenetic Biosciences
Xenetic Biosciences drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Framingham, USA HQ
7 Employees
Public company Type
XBIO · NYSE Ticker
Company details
- Status
- Public
- HQ
- Framingham, USA
- Employees
- 7
- Programs
- 1
- Drugs
- 1
- Patents
- 1
Xenetic Biosciences pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Xenetic Biosciences drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.